Future Retirement Success
  • Politics
  • Business
  • Investing
  • Stocks
  • Politics
  • Business
  • Investing
  • Stocks

Future Retirement Success

Politics

FDA Authorizes Moderna and Pfizer Updated Booster Shots Against Omicron for Kids as Young as 5 to 11

by October 12, 2022
October 12, 2022
FDA Authorizes Moderna and Pfizer Updated Booster Shots Against Omicron for Kids as Young as 5 to 11

Last month, the booster shots against Omicron got emergency authorization this week, and a CDC panel voted to recommend the shots for people over the age of 12.

The latest Covid booster was supposedly reformulated to ‘protect’ against Omicron subvariants.

The new COVID boosters were not tested on humans – only mice. . The Food and Drug Administration is only relying on the mice trial data.

On Wednesday, the FDA authorized Moderna and Pfizer the updated booster shots for children as young as 5 to 11.

From the news release:

Today, the U.S. Food and Drug Administration amended the emergency use authorizations (EUAs) of the Moderna COVID-19 Vaccine, Bivalent and the Pfizer-BioNTech COVID-19 Vaccine, Bivalent to authorize their use as a single booster dose in younger age groups. The Moderna COVID-19 Vaccine, Bivalent is authorized for administration at least two months following completion of primary or booster vaccination in children down to six years of age. The Pfizer-BioNTech COVID-19 Vaccine, Bivalent is authorized for administration at least two months following completion of primary or booster vaccination in children down to five years of age.

These bivalent COVID-19 vaccines include an mRNA component of the original strain to provide an immune response that is broadly protective against COVID-19 and an mRNA component in common between the omicron variant BA.4 and BA.5 lineages to provide better protection against COVID-19 caused by the omicron variant. The mRNA in these vaccines is a specific piece of genetic material that instructs cells in the body to make the distinctive “spike” protein of the original virus strain and the omicron variant lineages BA.4 and BA.5. The spike proteins of BA.4 and BA.5 are identical.

“Since children have gone back to school in person and people are resuming pre-pandemic behaviors and activities, there is the potential for increased risk of exposure to the virus that causes COVID-19. Vaccination remains the most effective measure to prevent the severe consequences of COVID-19, including hospitalization and death,” said Peter Marks, M.D., Ph.D. “While it has largely been the case that COVID-19 tends to be less severe in children than adults, as the various waves of COVID-19 have occurred, more children have gotten sick with the disease and have been hospitalized. Children may also experience long-term effects, even following initially mild disease. We encourage parents to consider primary vaccination for children and follow-up with an updated booster dose when eligible.” 

With today’s authorization, the monovalent Pfizer-BioNTech COVID-19 Vaccine is no longer authorized as a booster dose for individuals five through 11 years of age. Both the Moderna COVID-19 Vaccine and Pfizer-BioNTech COVID-19 Vaccine continue to be authorized for primary series administration in individuals six months of age and older.

Dr. Paul Offit, MD, a top vaccine expert and FDA adviser has warned last month that there is insufficient evidence to recommend the new booster shot for healthy young adults and said it could carry risks.

During an interview with CNN, Dr. Offit said this new Covid booster shot is unlikely to benefit healthy young people and said it’s ‘unfair to make them take a risk.’

Dr. Offit: “When you’re asking people to get a vaccine, I think there has to be clear evidence of benefit. And we’re not going to have clinical studies, obviously, before this launches, but you’d like to have at least human data on people getting this vaccine. You see a clear and dramatic increase in neutralizing antibiotics, and then at least you have a correlate of protection against BA4, BA5. Because if you don’t have that, if there’s not clear evidence of benefit, then it’s not fair [to ask people to take a risk]. The benefits should be clear.”

Watch the video below:

FDA advisor and vaccine maker Paul Offit: “A healthy young person is unlikely to benefit from a booster dose… If there’s not clear evidence of benefit, then it’s not fair to ask people to take a risk.” pic.twitter.com/SgBp5WZbMS

— Max Blumenthal (@MaxBlumenthal) September 24, 2022

The post FDA Authorizes Moderna and Pfizer Updated Booster Shots Against Omicron for Kids as Young as 5 to 11 appeared first on The Gateway Pundit.

0
FacebookTwitterGoogle +Pinterest
previous post
Author of Social Media Threat Proclaiming White Power And Threatening Murder Spree Against Blacks at County Fair Identified As Black Teen
next post
US Supreme Court Overturns Pennsylvania Court – Rules that Ballots with Even Minor Flaws Cannot Be Counted in Elections

You may also like

North Dakota urges residents to return Medicaid renewal...

June 7, 2023

Top Republican urges new SBA chief take ‘DOGE’...

February 20, 2025

Super Tuesday boosting Trump closer to clinching GOP...

March 6, 2024

Musk opens up about dinner party that soured...

February 19, 2025

Biden spends weekend at Rehoboth Beach house after...

January 21, 2023

Vance gives full-throated support for Israel, has choice...

October 7, 2024

Trump Cabinet picks increase odds Edward Snowden could...

November 20, 2024

Senate clears hurdle to passing aid package for...

February 12, 2024

In election victory, Trump’s gains went beyond the...

November 12, 2024

Iran’s attack on Israel shines spotlight on Tehran’s...

April 16, 2024

    Get free access to all of the retirement secrets and income strategies from our experts! or Join The Exclusive Subscription Today And Get the Premium Articles Acess for Free

    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Recent Posts

    • Elon Musk may speak to Trump aides in push to calm feud

      June 6, 2025
    • Everyone Talks About Leaving a Better Planet for Our Children: Why Don’t We Leave Better Children for Our Planet?

      June 6, 2025
    • MARK HALPERIN: Democrats try to construct a Frankenstein candidate while JD Vance gains momentum for 2028

      June 6, 2025
    • ‘Gone too far’: GOP lawmakers rally around Trump after Musk raises Epstein allegations

      June 6, 2025
    • Democrats begin to embrace Musk amid Trump spat after party railed against him as a ‘dictator’

      June 6, 2025
    • Trump administration defends US and Israeli sovereignty with new sanctions against four ICC judges

      June 5, 2025

    Categories

    • Business (8,149)
    • Investing (2,011)
    • Politics (15,544)
    • Stocks (3,130)
    • About us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: futureretirementsuccess.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2025 futureretirementsuccess.com | All Rights Reserved